A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach that paves the way for more personalized treatment strategies for patients with this deadly brain tumor.
Weight loss startup Calibrate raises $29M as part of private equity restructuring
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Calibrate, the weight loss startup that rose